Insulin Delivery Devices Market Analysis by Top Players (2019-2026): Novo Nordisk, Sanofi, BD, Eli Lilly, Medtronic, Animas, Beta Bionics
In 2019, North America accounted for the largest share of the global insulin delivery devices market. The large share of this segment can be attributed to the rising prevalence of diabetes and favorable reimbursement scenario in the U.S. and Canada, growing venture capital investments and issuance of IPOs in the U.S., and FDA approvals to increase the commercial availability of insulin delivery devices in the U.S.
View full press release